FOR IMMEDIATE DISTRIBUTION

JEFFERIES TO HOST 2ND ANNUAL HEALTHCARE CONFERENCE IN NEW YORK CITY

NEW YORK, June 16, 2008 -- Jefferies & Company, Inc., the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF), today announced that it will host its 2nd Annual Healthcare Conference from June 24-26, 2008 in New York City.

The conference will showcase more than 160 companies from around the world, public and private, as well as experts in the areas of biotechnology, CROs, healthcare facilities and services, healthcare IT services, medical devices and diagnostics, pharmaceutical services and specialty pharmaceuticals. The conference will be organized by sector focus and will include public and private company presentations and investor meetings.

“The upcoming presidential election creates new opportunities and challenges for healthcare companies and their investors,” said Steven Black, Director of Equity Research at Jefferies. “The impact of the election on the healthcare sector will be among the numerous timely and relevant issues addressed during the 2nd Annual Healthcare Conference, a forum for investors to learn more about the emerging growth companies and established industry leaders that are changing the face of the healthcare industry as we know it.”

Current conference participants include the following publicly-traded companies:

ACADIA Pharmaceuticals Inc. (ACAD)
Accentia Biopharmaceuticals, Inc. (ABPI)
Accuray Incorporated (ARAY)
Advocat Inc. (AVCA)
Air Methods Corporation (AIRM)
Albany Molecular Research, Inc. (AMRI)
Alcon, Inc. (ACL)
Alexion Pharmaceuticals, Inc. (ALXN)
Allergan, Inc. (AGN)
Allscripts, LLC (MDRX)
Almost Family, Inc. (AFAM)
Alpharma, Inc. (ALO)
Altus Pharmaceuticals Inc. (ALTU)
AMAG Pharmaceuticals, Inc. (AMAG)
Amedisys, Inc. (AMED)
American Oriental Bioengineering, Inc. (AOB)
AmSurg Corporation (AMSG)
Amylin Pharmaceuticals, Inc. (AMLN)
Antisoma plc (ASM LN)
Arena Pharmaceuticals, Inc. (ARNA)
Ariad Pharmaceuticals, Inc. (ARIA)
Array BioPharma Inc. (ARRY)
ARYx Therapeutics, Inc. (ARYX)
athenahealth, Inc. (ATHN)
AtriCure, Inc. (ATRC)
Auxilium Pharmaceuticals, Inc. (AUXL)
Bavarian Nordic A/S (BAVA DC)
BioForm Medical, Inc. (BFRM)
BioMarin Pharmaceutical Inc. (BMRN)
BioMimetic Therapeutics, Inc. (BMTI)
BioMS Medical Corp. (MS)
Bio-Reference Laboratories, Inc. (BRLI)
BMP Sunstone Corporation (BJGP)
Brookdale Senior Living Inc. (BKD)
Bruker Corporation (BRKR)
BTG plc (BGC LN)
Capital Senior Living Corporation (CSU)
Cardica, Inc. (CRDC)
Celgene Corporation (CELG)
Cephalon, Inc. (CEPH)
Cerner Corporation (CERN)
Charles River Laboratories, Inc. (CRL)
Chemed Corporation (CHE)
Computer Programs & Systems, Inc. (CPSI)
Covance Inc. (CVD)
Critical Homecare Solutions, Inc. (MBH)
Cubist Pharmaceuticals, Inc. (CBST)
Cyberonics, Inc. (CYBX)
Cynosure, Inc. (CYNO)
Cypress Bioscience, Inc. (CYPB)
CytRx Corporation (CYTR)
Dialysis Corporation of America (DCAI)
Discovery Laboratories, Inc. (DSCO)
DURECT Corporation (DRRX)
DUSA Pharmaceuticals, Inc. (DUSA)
Eclipsys Corporation (ECLP)
Emageon, Inc. (EMAG)
Emergency Medical Services (EMS)
Emergent BioSolutions Inc. (EBS)
Emeritus Corporation (ESC)
ev3 Inc. (EVVV)
Five Star Quality Care, Inc. (FVE)
Forest Laboratories, Inc. (FRX)
Genmab A/S (GEN DC)
Gentiva Health Services, Inc. (GTIV)
Genzyme Corporation (GENZ)
Haemonetics Corporation (HAE)
Halozyme Therapeutics, Inc. (HALO)
HealthSouth Corporation (HLS)
Hikma Pharmaceuticals plc (HIK LN)
Hill-Rom (HB)
HMS Holdings Corp. (HMSY)
Hologic, Inc. (HOLX)
ICON plc (ICLR)
Incyte Corporation (INCY)
Infinity Pharmaceuticals, Inc. (INFI)
Intercell AG (ICLL AV)
InterMune, Inc. (ITMN)
inVentiv Health, Inc. (VTIV)
Inverness Medical Innovations, Inc. (IMA)
IPC The Hospitalist Company, Inc. (IPCM)
ISIS Pharmaceuticals, Inc. (ISIS)
Keryx Biopharmaceuticals, Inc. (KERX)
Kindred Healthcare, Inc. (KND)
Kinetic Concepts, Inc. (KCI)
Laboratory Corporation of America Holdings (LH)
LCA-Vision, Inc. (LCAV)
Lev Pharmaceuticals, Inc. (LEVP)
LHC Group, Inc. (LHCG)
Lonza Group Ltd. (LONN VX)
MannKind Corporation (MNKD)
MDS Inc. (MDZ)
Medarex, Inc. (MEDX)
MedAssets, Inc. (MDAS)
Mentor Corporation (MNT)
Merge Healthcare Incorporated (MRGE)
Metabasis Therapeutics, Inc. (MBRX)
Molecular Insight Pharmaceuticals, Inc. (MIPI)
NicOx SA (COX FP)
NPS Pharmaceuticals, Inc. (NPSP)
Nuvelo, Inc. (NUVO)
Odyssey HealthCare, Inc. (ODSY)
Omnicare, Inc. (OCR)
Onyx Pharmaceuticals, Inc. (ONXX)
Optimer Pharmaceuticals, Inc. (OPTR)
Orexigen Therapeutics, Inc. (OREX)
Orthofix International NV (OFIX)
Osiris Therapeutics, Inc. (OSIR)
Oxford BioMedica plc (OXB LN)
Pharmaceutical Product Development, Inc. (PPDI)
PharmaNet Development Group Inc. (PDGI)
PharMerica Corporation (PMC)
Phase Forward (PFWD)
Power Medical Interventions, Inc. (PMII)
POZEN Inc. (POZN)
ProStrakan Group plc (PSK LN)
Protherics plc (PTI LN)
Psychiatric Solutions, Inc. (PSYS)
Quest Diagnostics Incorporated (DGX)
RadNet, Inc. (RDNT)
Regeneron Pharmaceuticals, Inc. (REGN)
RehabCare Group, Inc. (RHB)
ResMed Inc. (RMD)
Rigel Pharmaceuticals, Inc. (RIGL)
Savient Pharmaceuticals, Inc. (SVNT)
Skilled Healthcare, LLC (SKH)
Spectranetics Corporation (SPNC)
Sucampo Pharmaceuticals, Inc. (SCMP)
Sun Healthcare Group, Inc. (SUNH)
Sunesis Pharmaceuticals, Inc. (SNSS)
Sunrise Senior Living, Inc. (SRZ)
The Cooper Companies, Inc. (COO)
The TriZetto Group Inc. (TZIX)
TLC Vision Corporation (TLCV)
TomoTherapy Incorporated (TOMO)
Trinity Biotech plc (TRIB)
TyraTech, Inc. (TYR LN)
Universal Health Services, Inc. (UHS)
Vascular Solutions, Inc. (VASC)
Vectura Group plc (VEC LN)
Vital Images, Inc. (VTAL)
VIVUS, Inc. (VVUS)
XOMA Ltd. (XOMA)

The following private companies will also be featured:

Acceleron Pharma, Inc.
AGI Dermatics
Altea Therapeutics Corporation
Ambit BioSciences
Aperio Technologies, Inc.
CLP Healthcare Services Inc.
Cytochroma Inc.
EKR Therapeutics, Inc.
Eleme Medical Inc.
Endogastric Solutions, Inc.
GlobeImmune, Inc.
ISTO Technologies, Inc.
Ironwood Pharmaceuticals, Inc. (formerly Microbia, Inc.)
LifeHOUSE Retirement Properties, Inc.
Lux Biosciences, Inc.
Marwood Group, LLC
Novalar Pharmaceuticals, Inc.
Picis, Inc.
Portola Pharmaceuticals, Inc.
Protez Pharmaceuticals
SCYNEXIS, Inc.
Silverado Senior Living, Inc.
SurgRx
Transcept Pharmaceuticals, Inc.
Xoft, Inc.

An audio webcast of each presentation, both live and replay, will be available at the discretion of the presenting companies, and will be accessible at www.jefferies.com.

For further information about the 2nd Annual Healthcare Conference please contact your institutional sales representative or Jodi Pullman (212-284-2581; jpullman@Jefferies.com).

About Jefferies

Jefferies, a global investment bank and institutional securities firm, has served growing and mid-sized companies and their investors for 45 years. Headquartered in New York, with more than 25 offices around the world, Jefferies provides clients with capital markets and financial advisory services, institutional brokerage, securities research and asset management. The firm is a leading provider of trade execution in equity, high yield, convertible and international securities for institutional investors and high net worth individuals. Jefferies & Company, Inc. is the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF; www.jefferies.com)

MEDIA CONTACTS:

Tom Tarrant
(203)708-5989
ttarant@jefferies.com

Aimee Baxter
212.279.3115 ext.225
abaxter@cjpcom.com